Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine

A series of compounds derived from (1S,2S)-2-amino-1-(4-nitrophenyl) propane-1,3-diol have been designed, synthesized as potential APN inhibitors. Aminopeptidase N (APN) is involved in different physiological and pathological processes of tumor cells, including proliferation, invasion, apoptosis and...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 19; no. 17; pp. 5190 - 5198
Main Authors Jia, Meirong, Yang, Kanghui, Fang, Hao, Xu, Yingying, Sun, Siwei, Su, Li, Xu, Wenfang
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of compounds derived from (1S,2S)-2-amino-1-(4-nitrophenyl) propane-1,3-diol have been designed, synthesized as potential APN inhibitors. Aminopeptidase N (APN) is involved in different physiological and pathological processes of tumor cells, including proliferation, invasion, apoptosis and metastasis. Herein one series of compounds derived from commercially available (1S,2S)-2-amino-1-(4-nitrophenyl) propane-1,3-diol have been designed and synthesized. Furthermore, preliminary activity evaluation showed that some compounds elicited moderate inhibitory activity against APN with compounds 10e (IC50=6.1±0.5μM) possessing the best efficacy, which could be used as the lead compound in the future for anticancer agents research.
Bibliography:http://dx.doi.org/10.1016/j.bmc.2011.07.008
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2011.07.008